Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN374215 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Actin Related Protein 2/3 Complex, Subunit 2, 34kDa (ARPC2) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide from C Terminus of the protein sequence according to NP_005722.1, NP_690601.1. Genename: ARPC2
- Description
- Ammonium Sulphate Precipitation followed by antigen Affinity Chromatography using the immunizing peptide
- Reactivity
- Human, Mouse, Rat, Bovine, Canine
- Host
- Goat
- Antigen sequence
C-EMKTITGKTFSSR
- Epitope
- C-Term
- Vial size
- 0.1 mg
- Concentration
- 0.5 mg/mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references The profilin:actin complex localizes to sites of dynamic actin polymerization at the leading edge of migrating cells and pathogen-induced actin tails.
Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment.
Impaired T lymphocyte trafficking in mice deficient in an actin-nucleating protein, mDia1.
Li Y, Grenklo S, Higgins T, Karlsson R
European journal of cell biology 2008 Nov;87(11):893-904
European journal of cell biology 2008 Nov;87(11):893-904
Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment.
Fougner SL, Bollerslev J, Latif F, Hald JK, Lund T, Ramm-Pettersen J, Berg JP
The Journal of clinical endocrinology and metabolism 2008 Apr;93(4):1211-6
The Journal of clinical endocrinology and metabolism 2008 Apr;93(4):1211-6
Impaired T lymphocyte trafficking in mice deficient in an actin-nucleating protein, mDia1.
Sakata D, Taniguchi H, Yasuda S, Adachi-Morishima A, Hamazaki Y, Nakayama R, Miki T, Minato N, Narumiya S
The Journal of experimental medicine 2007 Sep 3;204(9):2031-8
The Journal of experimental medicine 2007 Sep 3;204(9):2031-8
No comments: Submit comment
No validations: Submit validation data